NCT01634139 - Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma | Biotech Hunter

Enrollment

403

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2015

Conditions

Asthma

Interventions

DRUG

Tiotropium low dose QD

2 actuations once daily in the evening

DRUG

Tiotropium high dose QD

2 actuations once daily in the evening

DRUG

Placebo

2 actuations once daily in the evening

Trial Locations (79)

Unknown

205.445.01002 Boehringer Ingelheim Investigational Site, Columbia

205.445.01001 Boehringer Ingelheim Investigational Site, Cincinnati

205.445.01010 Boehringer Ingelheim Investigational Site, Oklahoma City

205.445.01006 Boehringer Ingelheim Investigational Site, Charleston

205.445.01012 Boehringer Ingelheim Investigational Site, Arlington

205.445.01004 Boehringer Ingelheim Investigational Site, El Paso

205.445.35901 Boehringer Ingelheim Investigational Site, Sofia

205.445.35902 Boehringer Ingelheim Investigational Site, Sofia

205.445.35903 Boehringer Ingelheim Investigational Site, Sofia

205.445.35904 Boehringer Ingelheim Investigational Site, Sofia

205.445.35905 Boehringer Ingelheim Investigational Site, Sofia

205.445.02003 Boehringer Ingelheim Investigational Site, London

205.445.02001 Boehringer Ingelheim Investigational Site, Sherbrooke

205.445.49012 Boehringer Ingelheim Investigational Site, Berlin

205.445.49015 Boehringer Ingelheim Investigational Site, Berlin

205.445.49001 Boehringer Ingelheim Investigational Site, Bochum

205.445.49007 Boehringer Ingelheim Investigational Site, Dresden

205.445.49004 Boehringer Ingelheim Investigational Site, Ettenheim

205.445.49009 Boehringer Ingelheim Investigational Site, Koblenz

205.445.49014 Boehringer Ingelheim Investigational Site, Marburg

205.445.50201 Boehringer Ingelheim Investigational Site, Guatemala City

205.445.50202 Boehringer Ingelheim Investigational Site, Guatemala City

205.445.50203 Boehringer Ingelheim Investigational Site, Guatemala City

205.445.50204 Boehringer Ingelheim Investigational Site, Guatemala City

205.445.50205 Boehringer Ingelheim Investigational Site, Guatemala City

205.445.36003 Boehringer Ingelheim Investigational Site, Ajka

205.445.36001 Boehringer Ingelheim Investigational Site, Budapest

205.445.36002 Boehringer Ingelheim Investigational Site, Dombóvár

205.445.37104 Boehringer Ingelheim Investigational Site, Ādaži

205.445.37101 Boehringer Ingelheim Investigational Site, Baldone

205.445.37106 Boehringer Ingelheim Investigational Site, Balvi

205.445.37108 Boehringer Ingelheim Investigational Site, Daugavpils

205.445.37102 Boehringer Ingelheim Investigational Site, Ogre

205.445.37107 Boehringer Ingelheim Investigational Site, Rēzekne

205.445.37103 Boehringer Ingelheim Investigational Site, Riga

205.445.37105 Boehringer Ingelheim Investigational Site, Riga

205.445.37002 Boehringer Ingelheim Investigational Site, Šiauliai

205.445.37005 Boehringer Ingelheim Investigational Site, Utena

205.445.37003 Boehringer Ingelheim Investigational Site, Vilnius

205.445.47002 Boehringer Ingelheim Investigational Site, Oslo

205.445.35108 Boehringer Ingelheim Investigational Site, Amadora

205.445.35106 Boehringer Ingelheim Investigational Site, Aveiro

205.445.35101 Boehringer Ingelheim Investigational Site, Lisbon

205.445.35102 Boehringer Ingelheim Investigational Site, Lisbon

205.445.35107 Boehringer Ingelheim Investigational Site, Lisbon

205.445.35103 Boehringer Ingelheim Investigational Site, Porto

205.445.35105 Boehringer Ingelheim Investigational Site, Porto

205.445.40001 Boehringer Ingelheim Investigational Site, Bucharest

205.445.40004 Boehringer Ingelheim Investigational Site, Bucharest

205.445.40003 Boehringer Ingelheim Investigational Site, Cluj-Napoca

205.445.70002 Boehringer Ingelheim Investigational Site, Moscow

205.445.70005 Boehringer Ingelheim Investigational Site, Moscow

205.445.70008 Boehringer Ingelheim Investigational Site, Moscow

205.445.70011 Boehringer Ingelheim Investigational Site, Moscow

205.445.70001 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.445.70003 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.445.70004 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.445.70009 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.445.70010 Boehringer Ingelheim Investigational Site, Yaroslavl

205.445.82003 Boehringer Ingelheim Investigational Site, Guri-si

205.445.82002 Boehringer Ingelheim Investigational Site, Incheon

205.445.82001 Boehringer Ingelheim Investigational Site, Seoul

205.445.82005 Boehringer Ingelheim Investigational Site, Seoul

205.445.82006 Boehringer Ingelheim Investigational Site, Sungnam

205.445.46001 Boehringer Ingelheim Investigational Site, Stockholm

205.445.38017 Boehringer Ingelheim Investigational Site, Chernivtsi

205.445.38003 Boehringer Ingelheim Investigational Site, Dnipropetrovsk

205.445.38005 Boehringer Ingelheim Investigational Site, Donetsk

205.445.38011 Boehringer Ingelheim Investigational Site, Donetsk

205.445.38008 Boehringer Ingelheim Investigational Site, Kharkiv

205.445.38004 Boehringer Ingelheim Investigational Site, Kiev

205.445.38012 Boehringer Ingelheim Investigational Site, Kryvyi Rih

205.445.38001 Boehringer Ingelheim Investigational Site, Lviv

205.445.38009 Boehringer Ingelheim Investigational Site, Lviv

205.445.38016 Boehringer Ingelheim Investigational Site, Odesa

205.445.38006 Boehringer Ingelheim Investigational Site, Vinnytsia

205.445.38010 Boehringer Ingelheim Investigational Site, Zaporizhya

205.445.38002 Boehringer Ingelheim Investigational Site, Zaporizhzhya

205.445.44001 Boehringer Ingelheim Investigational Site, London